DUBLIN–(BUSINESS WIRE)–The “Digital Dose Inhalers – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Digital Dose Inhalers is estimated at US$3.2 Billion in 2023 and is projected to reach US$7.2 Billion by 2030, growing at a CAGR of 10.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
Market Growth: Understand the significant growth trajectory of the Metered Dose Inhalers segment, which is expected to reach US$4.4 Billion by 2030 with a CAGR of 10%. The Dry Powder Inhalers segment is also set to grow at 11.6% CAGR over the next 8 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 13.2% CAGR to reach $669.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Market Trends & Drivers
Digital Inhalers: A Significant Leap Forward for Respiratory Disease Management
Asthma & Respiratory Management as Twin Goals for Digital Technology
Respiratory Care Domain Perfectly Ripe for Adoption of Digital Devices
Healthcare Market Enjoys Striking Leap Forward with Increasing Influx of IoT
Number of Connected Medical Devices in Million: 2018-2025
Digital Dose Inhaler Technology Sees Proliferation of IoT
Advantages of the IoT-Enabled Digital Dose Inhaler
Market to Gain from Ongoing R&D Emphasis on Advanced Treatments for Pulmonary Diseases
Established Role of Inhaler Therapy in Respiratory Care Augurs Well
Growing Prevalence of Asthma Provides the Perfect Platform for Market Expansion
Role of Respiratory Inhalers in Asthma
Asthma Rescue Inhalers Medications
Asthma Long-Term Medications
Rising Prevalence of Asthma in Children Supports Growth
Asthma Prevalence in the US by Age
Asthma Prevalence in the US by Gender
Asthma Prevalence in the US by Race/Ethnicity
Slew of Smart Digital Technology & Tools for Asthma Care
Mounting Burden of COPD Drives Demand for Digital Dose Inhaler Technology
COPD Stats
Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
Global Cost of Respiratory Therapy by Disease (2023E): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others
Dry Powder Inhalers Set to Make Big Gains
Green Thumbs Up with Rising Uptake of Dry Powder Inhalers
Metered Dose Inhalers Continue to Exhibit Sustained Growth Momentum
Smart Inhalers Come to the Fore
Smart Inhalers Strike Right Chord with Medication Adherence Application
Artificial Intelligence Plays Significant Role in Automation and Improving Outcomes
Global Healthcare Artificial Intelligence Market by Application: 2023E
Artificial Intelligence to Add Sophistication to Inhaler Technology
New HME Method to Augment Inhaler Technology
3D Printing Seeks Role in Inhaler Manufacturing
Rise in Air Pollution Levels Trigger Demand for Respiratory Devices and Inhalers
World Ranking of Most Polluted Countries
Percentage Share Breakdown of Global Deaths Linked to Air Pollution
Ranking of Global Number of Deaths by Risk Factor
Uptrend in Healthcare Spending to Result in Improved Opportunities
Vulnerability of Growing Geriatric Population to Respiratory Diseases Enhances Prospects for Digital Inhalers
Key Questions Answered:
How is the Global Digital Dose Inhalers Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Beximco Pharmaceuticals Ltd., 3M Company, AstraZeneca and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors Featured:
Beximco Pharmaceuticals Ltd.
3M Company
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Cipla Ltd.
Chiesi Farmaceutici SpA
AptarGroup, Inc.
Bespak Europe Ltd.
Berry Global, Inc.
BIOCORP
Adherium (NZ) Limited
Amiko Digital Health Limited
Aerami Therapeutics
Cognita Labs
AireHealth
Key Attributes:
Report Attribute
Details
No. of Pages
507
Forecast Period
2023 – 2030
Estimated Market Value (USD) in 2023
$3.2 Billion
Forecasted Market Value (USD) by 2030
$7.2 Billion
Compound Annual Growth Rate
10.6%
Regions Covered
Global
For more information about this report visit https://www.researchandmarkets.com/r/we25ft
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
